Integrated cancer care provider GenesisCare has partnered with GE Healthcare in a US$130m contract to improve patient outcomes from cancer and heart disease.
GE Healthcare will supply and service the CT, MRI, PET/CT, SPECT, digital mammography, and Ultrasound equipment to GenesisCare’s cancer and cardiovascular disease treatment centres across Australia, the US, the UK and Spain.
Separately, the companies said that they plan to explore further partnership on research activities to improve clinical care and outcomes for patients around the world through technology, education, care pathway development, and theranostics – a personalised approach that combines molecular imaging and radiotherapy to seek and destroy advanced cancers without damaging healthy tissue.
“Cancer and heart disease haven’t stopped during this pandemic, and high-quality imaging and diagnosis will be in greater demand than ever as many people begin to feel more comfortable accessing screening services,” said GenesisCare founder and chief executive Dan Collins.
With more than 5,000 doctors and specialists reaching 400,000 patients across 440 locations internationally each year, Australia-based GenesisCare is expanding. It recently acquired major US integrated cancer care provider 21st Century Oncology and has said that it intends to invest US$300m there over the next three years.